<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) January 5, 2001
MODERN MEDICAL MODALITIES CORPORATION
(Exact name of registrant as specified in its charter)
NEW JERSEY 000-23416 22-3318886
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
1719 Route 10, SUITE 117
PARSIPPANY, NEW JERSEY 07054
(Address of principal executive offices, including zip code)
(973) 538-9955
(Registrant's telephone number, including area code)
<PAGE>
Item 4. Changes in Registrant's Certifying Accountants.
On January 5, 2001, Lazar, Levine & Felix, LLP ("Lazar"), the
independent certified public accountants for Modern Medical Modalities
Corporation (the "Company") were dismissed as the Company's independent
certified public accountants. During the year ended December 31, 1999 the report
by Lazar on the financial statements of the Company contained a going concern
opinion. During the Company's fiscal year ended December 31, 1999 and subsequent
period up to January 5, 2001, there were no disagreements with the former
accountant on any matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure, which disagreements if not
resolved to their satisfaction would have caused them to make reference in
connection with their opinion to the subject matter of the disagreement.
On January 5, 2001, upon receipt of approval of its Board of Directors,
the Company engaged Liebman, Goldberg & Drogin, LLP ("Liebman") to serve as the
Company's independent certified public accountants. During the year ended
December 31, 1998, Liebman audited the Company's financial statements and
rendered a report on the Company's financial statements containing a going
concern opinion. During the Company's fiscal year ended December 31, 1999, and
during any subsequent period through January 5, 2001, the Company did not
consult with Liebman on any accounting or auditing issues other than in
connection with the audit of the Company's December 31, 1998 financial
statements.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
*Exhibit 1 - Letter from Lazar.
*to be filed by amendment
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: January 12, 2001
MODERN MEDICAL MODALITIES CORPORATION
By: /s/ Roger Findlay
----------------------
Name: Roger Findlay
Title: President
